'United States Patent [19]

Total Page:16

File Type:pdf, Size:1020Kb

'United States Patent [19] ‘United States Patent [19] [111 3,907,780 Hughes [45] Sept. 23, 1975 [54] PREPARATION OF 3,502,722 3/1970 Newmann..... 260/453 X CARBODIIMIDE_CONTAINING 3,761,502 9/1973 Man et al .......................... .. 260/453 ISOCYANATES [75] lnventor: Jeffrey Hughes, Manchester, Primary Exami'f‘er_Lewls Gotts England Asszstant Exammer-Dolph H. Torrence Attorney, Agent, or Firm—Cushman, Darby & [73] Assignee: Imperial Chemical Industries Cushman Limited, London, England [ 22 1 F1‘e d: Jan .2, 1974 [57] ABSTRACT [21] Appl. No.: 429,807 A process for converting at least a proportion of the - _ _ 0 _ _ isocyanate groups in an organic isocyanate into carbo [30] Forelgn Apphcat‘on Prlonty Data diimide groups by heating the organic isocyanate with Jan. 15, 1973 United Kingdom ............... .. 2035/73 an organic phosphorus containing catalyst for the car bodiimide-forming reaction and an active hydrogen [52] U-S- Cl --------------- 260/239 A; 260/25 AT; containing compound as co-catalyst. Further reaction 260/77-5AT; 260/453 AR; 260/453 P of the carbodiimide groups with isocyanate groups re [5l] Int. Cl.2 ............ .. C07C 119/055; C0713 229/00 sults in the formation of uretonimines. The products [581 Field of Search ----- .- 260/453 P, 453 AR, 239 A of the process are useful in the manufacture of poly urethanes. [56] References Cited UNITED STATES PATENTS 10 Claims, N0 Drawings 3,056,835 10/1962 Monagle et al. .................. .. 260/551 3,907,780 1 2 PREPARATION OF CARBODIIMIDE-CONTAINING tion between carbodiimide groups and isocyanate ISOCYANATES groups takes place with formation of uretonimine groups. In order to permit this reaction to proceed to This invention relates to isocyanates and the manu near completion it is normally necessary to allow the facture of carbodiimides therefrom. reaction mixture to stand for a time after heating to It is known to convert isocyanates to carbodiimides form carbodiimide, for the uretonimine forming reac by heating and in particular it is known to carry out the tion to take place. Conversion to uretonimine may not reaction in the presence of phosphorus containing cata normally go‘to absolute completion and there some lysts such as organic phosphates and phosphoramides. times remains in the composition a small amount of We have now found that the efficiency of such cata carbodiimide which is not converted to uretonimine lysts may be improved by the incorporation of active despite the presence of excess isocyanate. This may be hydrogen containing compounds as co-catalyst. in the form of carbodiimide dimer. Thus according to the present invention there is pro Thus the present process may be used for the intro vided a process for converting at least a proportion of duction of a number of carbodiimide groups into a the isocyanate groups in an organic isocyanate into car polyisocyanate composition and the product allowed'to bodiimide groups by heating the organic isocyanate stand to convert at least a proportion of such groups to with an organic phosphorus containing catalyst for the uretonimine groups by further reaction. The ?nal prod carbodiimide-forming reaction and an active hydrogen ucts containing a proportion of uretonimine groups are containing compound as co-catalyst. useful as polyisocyanate compositions for the manufac Any organic isocyanate may be used in the present 20 ture of polyurethane foams having a valuable range of process which is particularly applicable to organic iso properties, by processes as described in our cope‘nding‘ cyanates containing two or more isocyanate groups, i.e. British Application No. 27442/71, wherein the prepa polyisocyanates. As examples of organic isocyanates ration and use of uretonimine group-containing tolyl which may be used there may be mentioned tolylene ene diisocyanate compositions is described. ' diisocyanates including the well-known commercially 25 In carrying out the process of the present invention available mixtures of the 2,4- and 2,6»isomers thereof, the amount of phosphorus containing catalyst used is a diphenylmethane diisocyanates and the polyisocyanate catalytic quantity and although this may vary widely we compositions, often described as crude diphenylmeth~ prefer to use from 0.1 % to 10% by weight of the isocy ane diisocyanates obtained by phosgenating a crude anate. mixture of polyamines produced by condensation of In respect of the co-catalyst, it will be realized that aniline and formaldehyde in the presence of acid cata use of an excess of active hydrogen~containing com lysts, and comprising diphenylmethane diisocyanate in pound will only result in loss of isocyanate groups‘and admixture with higher methylene bridged polyphenyl we therefore prefer to use from 0.05% to 5% especially polyisocyanates of higher isocyanate functionality. 0.05% to 1% of co-catalyst‘by weight of the isocyanate. Mixtures of polyisocyanates for example tolylene diiso 35 Although formation of carbodiimide groups may take cyanate and diphenylmethane diisocyanate may also be place with certain of the phosphorus containing cata used. The invention is not con?ned to pure distilled iso lysts at room temperature it is preferred that the mix cyanates but may also be used with crude non-distilled ture of isocyanate and catalyst be heated'atja tempera isocyanates such as crude products of the phosgenation ‘ ture of from 40°C to 220°C preferably 120°C to'200°C of tolylene diamines or residues obtained therefrom 40 in order that the reaction proceeds a reasonable rate. after distillation or some or all of the diisocyanate. The degree of heating or the length of reaction time re Refined, i.e. distilled or crystallized diphenylmethane quired will depend on the degree of conversion to car diisocyanates are solids and the invention is particu bodiimide which is required. The reaction conditions larly applicable to such isocyanates, as conversion of a will vary with different catalysts but can easily be deter proportion of the isocyanate groups in such isocyanates 45 mined experimentally. to carbodiimides gives liqui?ed compositions of the Organic phosphorus-containing catalysts which may said isocyanates. be used in the process of the invention include organic Although the process of the present invention may be phosphates or phosphonates, phosphoramides, phos used for conversion of isocyanates to carbodiimides it phonamides and triarylamidophosphates. has been found particularly useful for the conversion of Representative examples of catalysts include triethyl a proportion only of the isocyanate groups into carbo phosphate, tributyl phosphate, trimethyl phosphate, tri diimide groups and in this aspect is particularly useful phenyl phosphate, triallyl phosphate, bis(,B-chloroe for producing isocyanates containing a proportion of thyl)vinyl phosphonate, hexamethyl phosphoramide, uretonimine groups, say from 3% to 10% by weight, as N,N,N',N'-tetradodecyl dodecylphosphonamide and described in respect of tolylene diisocyanates in our co 55 triphenyl amido phosphate. pending British Application No. 27442/71. The trialkyl phosphate and phosphoramide type cata Uretonimine groups are produced by reacting an iso lysts are preferred as they enable a better control of the cyanate group with a carbodiimide group and may be reaction. The trialkyl phosphate type catalysts are rela easily introduced into an isocyanate composition by 60 tively inactive on standing at room temperature for converting some of the isocyanate groups to carbodiim long periods of time. The phosphoramide type catalysts ide groups by a reaction in which two isocyanate may be rendered inactive by complex formation with groups react to form a carbodiimide group for example an equivalent amount of chloroform or similar coupling by the process of the present invention and then allow agent. Although more vigorous catalysts are known and .ing the carbodiimide groups to react with a further por may be used e.g. phospholene oxides, phosphetane ox tion of the isocyanate to form uretonimine groups. ides, these tend to produce polymeric carbodiimides Once carbodiimide groups have been introduced into and are very active at room temperatures'and hence re for example, a tolylene diisocyanate composition, reac quire removal if a stable product is to be obtained. 3,907,780 3 4 Although a solvent may be used, this is not normally ditions and the similar‘degree of conversion obtained found to be necessary if the isocyanate is liquid. using a co-catalyst and a shorter heating cycle. Any active hydrogen-containing compound may be Examples 1, 3, 5 and 7 are for purposes of compari used as co-catalyst the only criterion being that the son. compound should contain at least one hydrogen atom 5 EXAMPLES 8 - 1'0 : capable of taking part in the Zerewitinoff reaction. We have found that water is a preferred co-catalyst 4,4’-diisocyanatodiphenylmethane (containing and is operative even in small amounts of the order of traces of the 2,4’-isomer) was heated at 175°C for 4 hours under an atmosphere of ‘nitrogen with the cata 0.05 % to 1 %. Water introduced into the reaction mix~ lysts shown in Table 2. After cooling rapidly to below ture may react to form ureas and biurets and such com pounds which themselves contain active hydrogen 60°C, the isocyanate content was determined by react ing a weighed amount of the sample with a standard so atoms act as co-catalysts. ' Other active hydrogen containing compounds which lution of di-n-butylamine, then back-titrating with acid may be used include aromatic or aliphatic amines such to determine the excess amine. as aniline and diethylamine, phenols, alcohols, carbox The additional activity of the co-catalyst system is ylic acids, mercaptans, acetoacetonates, malononi clearly shown by the increased conversion to carbodi triles, B-diketones or other groups having active hydro imide groups as measured by the fall in isocyanate gen atoms by virtue of being adjacent to electron with group content. drawing groups. Infra red spectroscopy showed the presence of sub Carbodiimides made by the process of the present in 20 stantial quantities of carbodiimide and uretonimine vention may be used in the manufacture of polymers groups in the product from Example 10.
Recommended publications
  • E-Catalog Version 18.0 Release Date: 05-10-2013
    E-Catalog Version 18.0 Release Date: 05-10-2013 ChemGenes Corporation is now ISO 9001:2008 Certified Company Bio Technology Products & Manufacturer of DNA-RNA Intermediates 33 Industrial Way Wilmington, MA 01887 USA Tel: 978-694-4500 Fax: 978-694-4502 Toll Free: 800-762-9323 Email: [email protected] www.chemgenes.com Product Highlight Extensive Product Lines: DNA amidites: Bulk Quantities for therapeutics grade oligo synthesis Natural and modified DNA amidites Natural & modified RNA amidites : Bulk Quantities 2’-O-Methyl amidites: Bulk Quantities RNA Synthesis in Reverse Direction TOM amidites for RNA synthesis : Bulk Quantities 2’-O-ALE amidites 2’-O-PivOM amidites 2’-Fluoro amidites Non-Cleavable Inert Supports ETT & BMT : Bulk Quantities DDTT Sulfurizing Reagent UnyLinker Universal Support Akta Oligonucleotide Synthesizer Reagents N-Alkylated nucleosides and amidites 5-Azacytidine and 5-Aza-2’-deoxycytidine Thio uridines & thymidines nucleosides and amidites 6 & 5-FAM NHS Esters 6 & 5-FAM-(C-6 linker) amidites Biotin (BB)-(urea nitrogen protected) Supports & amidites Polyethylene glycol (PEG) (MW. 2000 and 4500) amidites 5’-MMTr nucleoside amidites (Purines: A & G) 8-Methyl dG & rG amidites 8-Oxo dA & dG amidites 5’-O-Methyl DNA amidites Fmoc Protected Nucleoside amidites 5-Formyl dU amidites Ammonia Free Deprotection Reagents Thiol modifiers (acyclic and cyclic) DNA and RNA Purification kit Toll Free: (800) 762-9323 33 Industrial Way, Wilmington, MA 01887 • T: (978) 694-4500 • F: (978) 694-4502 www.chemgenes.com Email: [email protected] Experience Nucleic Acid Expertise Since 1981, the products and services provided by ChemGenes Corporation continue to accelerate the pace of DNA/RNA oligonucleotide synthesis, research, and develop- ment in the pharmaceutical and biotechnology industry.
    [Show full text]
  • Surrogates to Synthesize Phosphonates and Phosphinates
    UPDATES DOI: 10.1002/adsc.202000511 Disulfide Promoted CÀ P Bond Cleavage of Phosphoramide: “P” Surrogates to Synthesize Phosphonates and Phosphinates Fei Hou,+a Xing-Peng Du,+a Anwar I. Alduma,a Zhi-Feng Li,b,* Cong-De Huo,a Xi-Cun Wang,a Xiao-Feng Wu,a, c,* and Zheng-Jun Quana,* a International Scientific and Technological Cooperation Base of Water Retention Chemical Functional Materials, College of Chemistry and Chemical Engineering, Northwest Normal University, Lanzhou, Gansu 730070, People’s Republic of China E-mail: [email protected]; [email protected] b College of Chemical Engineering and Technology, Key Laboratory for New Molecule Design and Function of Gansu Universities, Tianshui Normal University, Tianshui 741001, People’s Republic of China E-mail: [email protected] c Department of Chemistry, University of Liverpool, Crown Street, Liverpool L69 7ZD, UK + These authors contributed equally to this work. Manuscript received: April 28, 2020; Revised manuscript received: July 29, 2020; Version of record online: ■■■, ■■■■ Supporting information for this article is available on the WWW under https://doi.org/10.1002/adsc.202000511 Abstract: A metal-free CÀ P bond cleavage reaction The CÀ P bond cleavage is mostly realized through transition metal catalysis (Scheme 1A, a).[15] In addi- is described herein. Phosphoramides, a phosphine [16] source, can react with alcohols to produce phospho- tion, Davidson has demonstrated the photocatalytic nate and phosphinate derivatives in the presence of acyl CÀ P bond cleavage of acyl phosphine oxide under UV irradiation (Scheme 1A, b). Recently, Wang and a disulfide. PÀ H2, P-alkyl, and P,P-dialkyl phosphor- amides can be used as substrates to obtain the co-workers have reported the acyl phosphorus CÀ P corresponding pentavalent phosphine products.
    [Show full text]
  • The Synthesis and Study of Oligo(Deoxy)Ribonucleotides and Their Analogues
    The Synthesis and Study of Oligo(deoxy)ribonucleotides and their Analogues. by Susanne Ebel A Thesis Presented for the Degree of Doctor of Philosophy University of Edinburgh 1993 \ 4/ 11i1t I declare that this thesis is my own composition and that the work of which it is a record was carried out by myself unless otherwise acknowledged. No part of this thesis has been submitted in any previous application for a higher degree. Susanne Ebel. 1993 2 I wish to thank - my supervisor Prof.; Tom Brown for offering the opportunity to do this Ph.D. and giving advice and encouragement throughout, - Dr. Brian Sproat for the generous gift of his biotin-phosphoramidite, -the OSWEL DNA Service for the use of their facilities, - Dr. A. Lane of the NIMR who did all the excellent NMR work on G.A mismatches, - Dr. P. Hendry of the OSORO for his help with ribozyme-cleavage analysis, - David Will for being the most critical of all the colleagues in the group, - all the people in the Brown group for being fun to work with, - and Edinburgh University for use of their facilities. Proton, Carbon-13 spectra were recorded by John Millar and Heather Grant, FAB-Mass spectra were recorded by Alan Taylor. 3 AbbreviaUanz A260 absorbance unit at 260nm [ml-1 ] AMP adenosine mono-phosphate ATP adenosine tn-phosphate Bio single-addition biotin phosphoramidite as shown in chapter 2 Bz benzoyl Cbio biotin-phosphoramidite as shown in chapter 2 conc. concentrated CPG controlled pore glass Ctmp 1 -(2-chloro-4-tolyl)-4-methoxypipenidi n-4-yl dA 2Oxy adenosine dO 2'-deoxy cytidine dG 2'-deoxy guanosine dil.
    [Show full text]
  • Synthesis and Mechanisms of Phosphoramidates
    Review Openingmolecules Up the Toolbox: Synthesis and Mechanisms of Phosphoramidates Emeka J.Review Itumoh 1,2,3, Shailja Data 1,3 and Erin M. Leitao 1,3,* 1 SchoolOpening of Chemical Sciences, up the The Toolbox:University of Auckland, Synthesis 23 Symonds and Street, Mechanisms Auckland 1010, Newof Zealand; Phosphoramidates [email protected] (E.J.I.); [email protected] (S.D.) 2 Department of Industrial Chemistry, Ebonyi State University, Abakaliki 480001, Ebonyi State, Nigeria 3 The MacDiarmidEmeka J. Itumoh Institute1,2,3 for, Shailja Advanced Data 1,3 Materialsand Erin and M. LeitaoNanotechnology,1,3,* Wellington 6140, New Zealand * Correspondence:1 School of Chemicalerin.leitao@ Sciences,auckland.ac.nz; The University Tel.: of Auckland, +64-9923-5567 23 Symonds Street, Auckland 1010, New Zealand; [email protected] (E.J.I.); [email protected] (S.D.) Academic Editor: Frederik Wurm 2 Department of Industrial Chemistry, Ebonyi State University, Abakaliki 480001, Ebonyi State, Nigeria 3 Received: 3 TheJuly MacDiarmid 2020; Accepted: Institute 11 for Augu Advancedst 2020; Materials Published: and Nanotechnology, 12 August 2020 Wellington 6140, New Zealand * Correspondence: [email protected]; Tel.: +64-9923-5567 Abstract:Academic This review Editor: Frederik covers Wurm the main synthetic routes to and the corresponding mechanisms of phosphoramidateReceived: 3 July formation. 2020; Accepted: The 11 August synthetic 2020; Published: routes 13can August be 2020separated into six categories: salt elimination,Abstract: oxidativeThis review cross-coupling, covers the main azide, synthetic reduction, routes to andhydrophosphinylation, the corresponding and phosphoramidate-aldehyde-dienophilemechanisms of phosphoramidate formation. (PAD). The Examples synthetic routesof some can be separatedimportant into compounds six synthesizedcategories: through salt elimination,these routes oxidative are provided.
    [Show full text]
  • Synthesis and Characterization of New Phosphoramide Ligands for the Preparation of Luminescent Manganese and F-Block
    Master's Degree Programme in Sustainable Chemistry and Technologies Final Thesis Synthesis and characterization of new phosphoramide ligands for the preparation of luminescent manganese and f-block metal complexes Supervisor Ch. Prof. Marco Bortoluzzi Graduand Alberto Gobbo Matriculation Number 849283 Academic Year 2018 / 2019 INDEX 1. INTRODUCTION ...................................................................................................................... 1 1.1 d-block luminescence ...................................................................................................... 1 1.2 Manganese luminescence ................................................................................................. 4 1.2.1 Manganese(II) luminescent complexes ...................................................................... 7 1.3 Lanthanides ................................................................................................................... 10 1.3.1 General features ...................................................................................................... 10 1.3.2 Extraction and purification ...................................................................................... 11 1.3.3 Electronic configuration and coordination chemistry ............................................. 12 1.3.4 Spectroscopic and magnetic properties .................................................................. 13 1.3.5 Photoluminescence ................................................................................................
    [Show full text]
  • From C-O to C-C Through Nickel Coupling
    From C–O to C–C through Nickel Coupling MeO2C CO2Me >99% yield Ph O Homocoupling R = S O OMOM OMe 80% yield Suzuki- Kumada 95% yield O Miyaura O R = RO R = S NEt2 NEt2 R' O O O R = R = P (OEt) Suzuki- Kumada 2 Miyaura n-octyl Kumada R = Me 92% yield NOMe i86% yield Ph N H Nathan Bennett 95% yield Group Meeting May 7, 2011 Title Page Ni Chemistry Timeline Initial Studies 1966 Saito and Yamamoto Et2Ni(bpy) 1960 1970 1980 1990 2000 Saito, T. and Yamamoto, A. N N Et Et2AlOEt vacuum + Ni(acac)2 + Ni + Et O 110 °C N 2 N Et –20 ! –10 °C Et2Ni(bpy) J. Am. Chem. Soc. 1966, 88, 5198. Timeline1 Saito Ni Chemistry Timeline Initial Studies 1966 1971 Saito and Yamamoto Semmelhack Et2Ni(bpy) Ni(COD)2 1960 1970 1980 1990 2000 Semmelhack, M. F. Ni(COD)2 Br DMF 52 °C 82% yield Ullmann Coupling Comparison Cu Bronze Br cymene 180 °C 60% yield Ni: Semmelhack, M. F. J. Am. Chem. Soc. 1971, 93, 5908. Ullmann Coupling: Fanta, P. E. Chem. Res. 1964, 64, 613. Timeline1 Semmelhack Ni Chemistry Timeline Initial Studies 1966 1971 1975 Saito and Yamamoto Semmelhack Semmelhack Et2Ni(bpy) Ni(COD)2 Ni(PPh3)4 1960 1970 1980 1990 2000 Semmelhack, M. F. OMe n yield (%) MeO I 2 81 Ni(PPh3)4 3 83 n n DMF, 55 °C 4 76 MeO I 5 85 6 38 OMe J. Am. Chem. Soc. 1975, 97, 3873. J. Am. Chem. Soc. 1981, 103, 646.
    [Show full text]
  • Coupling Activators for the Oligonucleotide Synthesis Via Phosphoramidite Approach
    Tetrahedron 69 (2013) 3615e3637 Contents lists available at SciVerse ScienceDirect Tetrahedron journal homepage: www.elsevier.com/locate/tet Tetrahedron report number 1002 Coupling activators for the oligonucleotide synthesis via phosphoramidite approach Xia Wei a,b,* a AM Biotechnologies, LLC., 12521 Gulf Freeway, Houston, TX 77034, USA b University of Houston-Clear Lake, 2700 Bay Area Boulevard, Houston, TX 77058, USA article info Article history: Received 4 August 2012 Available online 7 March 2013 Contents 1. Introduction . ................................................3616 1.1. Nucleoside phosphoramidites . ......................3616 1.2. Typical oligonucleotide synthesis via nucleoside phosphoramidite approach . ......................3617 2. Azole coupling activators . ................................................3619 2.1. 1H-Tetrazole and its activation mechanism . ......................3619 2.2. Modified tetrazole coupling activators . ......................3620 2.2.1. 5-Nitrophenyl-1H-tetrazole (NPT) . ......................3620 2.2.2. 5-(Bis-3,5-trifluoromethylphenyl)-1H-tetrazole (Activator 42) . .................................3622 2.2.3. 5-Ethylthio-1H-tetrazole (ETT) . ......................3622 2.2.4. 5-Benzylthio-1H-tetrazole (BTT) . ......................3623 2.2.5. 5-Methylthio-1H-tetrazole (MTT) . ......................3624 2.2.6. 5-Mercapto-tetrazole (MCT) . ......................3624 2.2.7. Chiral tetrazoles for stereocontrolled synthesis . ......................3624 2.3. Other azole coupling activators . ......................3625
    [Show full text]
  • E-Catalog Version 19.0
    E-Catalog Version 19.0 ChemGenes Corporation is now ISO 9001:2008 Certified Company Bio Technology Products & Manufacturer of DNA-RNA Intermediates 33 Industrial Way Wilmington, MA 01887 USA Tel: 978-694-4500 Fax: 978-694-4502 Toll Free: 800-762-9323 Email: [email protected] www.chemgenes.com Product Highlight Extensive Product Lines: DNA amidites: Bulk Quantities for therapeutics grade oligo synthesis Natural and modified DNA amidites Natural & modified RNA amidites : Bulk Quantities 2’-O-Methyl amidites: Bulk Quantities RNA Synthesis in Reverse Direction TOM amidites for RNA synthesis : Bulk Quantities 2’-O-ALE amidites 2’-O-PivOM amidites 2’-Fluoro amidites Non-Cleavable Inert Supports ETT & BMT : Bulk Quantities DDTT Sulfurizing Reagent UnyLinker Universal Support Akta Oligonucleotide Synthesizer Reagents N-Alkylated nucleosides and amidites 5-Azacytidine and 5-Aza-2’-deoxycytidine Thio uridines & thymidines nucleosides and amidites 6 & 5-FAM NHS Esters 6 & 5-FAM-(C-6 linker) amidites Biotin (BB)-(urea nitrogen protected) Supports & amidites Polyethylene glycol (PEG) (MW. 2000 and 4500) amidites 5’-MMTr nucleoside amidites (Purines: A & G) 8-Methyl dG & rG amidites 8-Oxo dA & dG amidites 5’-O-Methyl DNA amidites Fmoc Protected Nucleoside amidites 5-Formyl dU amidites Ammonia Free Deprotection Reagents Thiol modifiers (acyclic and cyclic) DNA and RNA Purification kit Toll Free: (800) 762-9323 Toll Free: 33 Industrial(800) Way, Wilmington, 762-9323 MA 01887 • T: (978) 694-4500 • F: (978) 694-4502 33 Industrial Way, Wilmington, MA 01887 • T: (978) 694-4500 • F: (978) 694-4502 www.chemgenes.com Email: [email protected] Experience Nucleic Acid Expertise Since 1981, the products and services provided by ChemGenes Corporation continue to accelerate the pace of DNA/RNA oligonucleotide synthesis, research, and develop- ment in the pharmaceutical and biotechnology industry.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0152079 A1 Cherpeck Et Al
    US 20100152079A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0152079 A1 Cherpeck et al. (43) Pub. Date: Jun. 17, 2010 (54) LUBRICATING OL COMPOSITIONS (22) Filed: Dec. 16, 2008 CONTAINING A TETRAALKYL-NAPTHALENE-18 DIAMINE Publication Classification ANTOXDANT (51) Int. Cl. CIOM 39/06 (2006.01) (75) Inventors: Richard E. Cherpeck, Cotati, CA CIOM. I.33/2 (2006.01) (US); Carrie Y. Chan, Daly City, CIOM 37/10 (2006.01) CA (US); Gaurav Bhalla, Hercules, CA (US) (52) U.S. Cl. .......................... 508/362; 508/556; 508/370 (57) ABSTRACT Correspondence Address: Disclosed is a lubricating oil composition containing an oil of CHEVRON CORPORATION lubricating viscosity and a N.N.N',N'-tetraalkyl-naphthalene P.O. BOX 6006 1,8-diamine and at least one additive selected from antioxi SAN RAMON, CA 94583-0806 (US) dants, dispersants, and detergents which together provide superior oxidation inhibition and are suitable lubricants for (73) Assignee: Chevron Oronite Company LLC automotive and truck crankcase lubricants; as well as trans mission lubricants, gear lubricants, hydraulic fluids, com (21) Appl. No.: 12/336,128 pressor oils, diesel and marine lubricants. US 2010/0152079 A1 Jun. 17, 2010 LUBRICATING OL COMPOSITIONS esters and Sulfurized ester-olefins and a secondary aliphatic CONTAINING A amine. U.S. Pat. No. 6,306,802 discloses of an antioxidant TETRAALKYL-NAPTHALENE-18 DIAMINE mixture containing a combination of an oil soluble molybde ANTIOXDANT num compound and an aromatic amine. 0005 Commonly, antioxidant compounds which were FIELD OF THE INVENTION intended to decompose hydroperoxides or peroxides (includ 0001. The present invention is directed in part to a lubri ing Sulfurized olefins, metal dithiocarbamates, dithio cating oil composition containing an oil of lubricating vis phospates, phosphites, thioesters, etc.) are increasingly diffi cosity, a N.N.N',N'-tetraalkyl-naphthalene-1,8-diamine and a cult to incorporate into the finished lubricant due to the lubricating oil additive.
    [Show full text]
  • Phosphotriesterase: an Enzyme in Search of Its Natural Substrate
    Advances in Enzymology and Related Areas of Molecular Biology, Volume 74 Edited by Daniel L. Punch Copyright © 2000 by John Wiley & Sons, Inc. PHOSPHOTRIESTERASE: AN ENZYME IN SEARCH OF ITS NATURAL SUBSTRATE By FRANK M. RAUSHEL, Department of Chemistry, Texas A&M Universiq, College Station, Texas 77843 and HAZEL M. HOLDEN, Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53 706 CONTENTS 1. Introduction 11. Structure A. Protein Sequence B. Active Site Residues C. Reconstitution of Apo-Enzyme D. "'Cd-NMR Spectroscopy E. EPR Spectroscopy F. Mutagenesis ofActive Site Residues G. Structure of the Apo-Form of Phosphotriesterase H. Structure of the Cd2'/Cd2'-Substituted Enzyme 1. Structure of the Zn2'/Zn2'-Containing Enzyme J. Comparison with Other Enzymes K. Modifications to Carbamylated Lysine 111. Mechanism of Action A. Stereochemistry at Phosphorus Center B. Determination of Rate-Limiting Steps C. Effects of Solvent Viscosity D. pH-Rate Profiles E. The Role of Binuclear Metal Center F. Heavy Atom Isotope Effects G. Mechanism-Based Inhibitors H. Mechanism ofAction IV. Substrate Specificity A. Alterations to Substrate Specificity V. Summary Acknowledgments References Advances in Enzymology and Related Areas of Molecular Biology, Volume 74: Mechanism of Enzyme Action, Part B, Edited by Daniel L. Punch ISBN 0-471-34921-6 0 1998 John Wiley & Sons, Inc. 51 52 RAUSHEL AND HOLDEN I. Introduction Approximately 25 years ago two strains of unrelated soil bacteria (Pseudomonasdiminuta and Flavobacterium sp.) were isolated that had the ability to hydrolyze, and thus detoxify, a broad range of organophosphate in- secticides and military-type nerve agents (Munnecke, 1976). The specific chemical reaction catalyzed by these bacterial strains, as exemplified with the insecticide paraoxon, is shown in Scheme 1.
    [Show full text]
  • Phosphorus Compounds of Natural Origin: Prebiotic, Stereochemistry, Application
    S S symmetry Review Phosphorus Compounds of Natural Origin: Prebiotic, Stereochemistry, Application Oleg I. Kolodiazhnyi V.P. Kukhar’ Institute of Bioorganic Chemistry and Petrochemistry, NAS of Ukraine, Murmanska st., 1, 02094 Kyiv, Ukraine; [email protected] Abstract: Organophosphorus compounds play a vital role as nucleic acids, nucleotide coenzymes, metabolic intermediates and are involved in many biochemical processes. They are part of DNA, RNA, ATP and a number of important biological elements of living organisms. Synthetic compounds of this class have found practical application as agrochemicals, pharmaceuticals, bioregulators, and othrs. In recent years, a large number of phosphorus compounds containing P-O, P-N, P-C bonds have been isolated from natural sources. Many of them have shown interesting biological properties and have become the objects of intensive scientific research. Most of these compounds contain asymmetric centers, the absolute configurations of which have a significant effect on the biological properties of the products of their transformations. This area of research on natural phosphorus compounds is still little-studied, that prompted us to analyze and discuss it in our review. Moreover natural organophosphorus compounds represent interesting models for the development of new biologically active compounds, and a number of promising drugs and agrochemicals have already been obtained on their basis. The review also discusses the history of the development of ideas about the role of organophosphorus compounds and stereochemistry in the origin of life on Earth, starting from the prebiotic period, that allows us in a new way to consider this most important problem of fundamental science. Citation: Kolodiazhnyi, O.I. Keywords: stereochemistry; prebiotic chemistry; origin of life; DNA; RNA; phosphagens; nucleotides; Phosphorus Compounds of Natural Origin: Prebiotic, Stereochemistry, natural phosphonic acids; antibiotics; phosphonopeptides; phosphoramidates Application.
    [Show full text]
  • The Effects of Neuropathy-Inducing Organophosphate Esters on Chick Dorsal Root Ganglia Cell Cultures
    THE EFFECTS OF NEUROPATHY-INDUCING ORGANOPHOSPHATE ESTERS ON CHICK DORSAL ROOT GANGLIA CELL CULTURES. By Christiane Massicotte Dissertation submitted to the Faculty of the Virginia Polytechnic institute & State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Veterinary Medical Sciences APPROVED ________________________ ______________________ Marion F. Ehrich (Chairman) Bernard S. Jortner ________________________ _____________________ Cornelis Van der Schyf Bradley Klein ________________________ _____________________ Jeffrey Bloomquist Karen D. Inzana September 2001 Blacksburg, Virginia Keywords: Organophosphate, Neuropathy, ATP, mitochondria i. ABSTRACT THE EFFECTS OF NEUROPATHY-INDUCING ORGANOPHOSPHATE ESTERS ON CHICK DORSAL ROOT GANGLIA CELL CULTURES. By: Christiane Massicotte Committee Chairman, Dr. Marion F. Ehrich Veterinary Medical Sciences Cultures of dorsal root ganglia (DRG) can achieve neuronal maturation with axons, making them useful for neurobiological studies. They have not, however, previously been used to investigate subcellular events that occur following exposure to neuropathy-inducing organophosphorus (OP) esters. Recent studies in other systems demonstrated alterations of ATP concentrations and changes in mitochondrial transmembrane potential (∆Ψm) following exposure to neuropathy-inducing OP compounds, suggesting that mitochondrial dysfunction occurs. The present dissertation proposed an investigation using chick embryo DRG cultures to explore early mechanisms associated with exposure to these toxicants. This approach uses an in vitro neuronal system from the species that provides the animal model for OP-induced delayed neuropathy (OPIDN). DRG were obtained from 9-10 day old chick embryos, and grown for 14 days in minimal essential media (MEM) supplemented with bovine and human placental sera and growth factors. Cultures were then treated with 1 µM OP compounds, or the DMSO vehicle control.
    [Show full text]